A Study to Assess the Food Effect and the Relative Bioavailability of the Cabotegravir (CAB) Pediatric Dispersible Tablet (DT) Formulation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study will assess the relative bioavailability of the CAB DT formulation relative to that of the CAB IR formulation and to assess the effect of food on the CAB DT formulation.
Epistemonikos ID: 4146322d54fc6f978dada5b368ed4fa854945efc
First added on: Oct 02, 2023